Skip to Content
Merck
CN

Plasmodium species co-infection as a cause of treatment failure.

Travel medicine and infectious disease (2011-12-06)
A Smith, J Denholm, J Shortt, D Spelman
ABSTRACT

We report a case of Plasmodium falciparum and Plasmodium malariae coinfection with associated failure of clinical response to artemether + lumefantrine therapy. This case highlights the need to consider co-infection in the setting of apparent treatment failure and the impact of mixed species infection upon host dynamics and clinical presentation. Recognition of malarial co-infection is clinically important for determining appropriate therapy and preventing disease sequelae.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lumefantrine